Amedisys Inc (AMED) — Strategic Asset Allocation Index
Amedisys Inc (AMED) has a Strategic Asset Allocation Index of 5.9% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $69.80 Million) total $69.80 Million, measured against net assets of $1.18 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Amedisys Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Amedisys Inc Strategic Asset Allocation Index (2001–2024)
This chart shows how Amedisys Inc's Strategic Asset Allocation Index has evolved across 24 annual periods from 2001 to 2024. As of December 2024, the index stands at 5.9%, representing strategic assets of $69.80 Million against net assets of $1.18 Billion USD. See AMED FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Amedisys Inc (2001–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Amedisys Inc from 2001 to 2024, covering 24 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Amedisys Inc (AMED) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 5.9% | $69.80 Million | $- | $69.80 Million | $1.18 Billion | ▲ +0.0 pp |
| 2023 | 5.9% | $66.10 Million | $- | $66.10 Million | $1.12 Billion | ▼ -1.0 pp |
| 2022 | 6.9% | $76.53 Million | $16.03 Million | $60.50 Million | $1.11 Billion | ▼ -10.8 pp |
| 2021 | 17.7% | $172.79 Million | $119.69 Million | $53.10 Million | $976.32 Million | ▲ +13.0 pp |
| 2020 | 4.7% | $37.92 Million | $23.72 Million | $14.20 Million | $810.74 Million | ▼ -5.3 pp |
| 2019 | 9.9% | $63.81 Million | $28.11 Million | $35.70 Million | $641.51 Million | ▼ -3.4 pp |
| 2018 | 13.4% | $64.50 Million | $29.40 Million | $35.10 Million | $482.63 Million | ▲ +2.2 pp |
| 2017 | 11.1% | $57.52 Million | $31.12 Million | $26.40 Million | $516.43 Million | ▼ -2.9 pp |
| 2016 | 14.1% | $64.80 Million | $37.00 Million | $27.80 Million | $461.14 Million | ▼ -2.6 pp |
| 2015 | 16.7% | $68.40 Million | $42.70 Million | $25.70 Million | $410.44 Million | ▼ -17.9 pp |
| 2014 | 34.6% | $137.46 Million | $137.46 Million | $- | $397.76 Million | ▼ -8.1 pp |
| 2013 | 42.7% | $159.03 Million | $159.03 Million | $- | $372.48 Million | ▲ +8.2 pp |
| 2012 | 34.5% | $156.71 Million | $156.71 Million | $- | $454.23 Million | ▲ +5.9 pp |
| 2011 | 28.6% | $148.54 Million | $148.54 Million | $- | $520.15 Million | ▲ +12.8 pp |
| 2010 | 15.7% | $138.55 Million | $138.55 Million | $- | $879.72 Million | ▲ +3.3 pp |
| 2009 | 12.5% | $91.92 Million | $91.92 Million | $- | $736.34 Million | ▼ -1.6 pp |
| 2008 | 14.1% | $79.26 Million | $79.26 Million | $- | $562.12 Million | ▼ -1.2 pp |
| 2007 | 15.3% | $68.31 Million | $68.31 Million | $- | $447.82 Million | ▲ +0.7 pp |
| 2006 | 14.5% | $52.96 Million | $52.96 Million | $- | $364.01 Million | ▲ +0.3 pp |
| 2005 | 14.2% | $27.39 Million | $27.39 Million | $- | $192.60 Million | ▲ +7.5 pp |
| 2004 | 6.7% | $10.00 Million | $10.00 Million | $- | $148.47 Million | ▼ -7.3 pp |
| 2003 | 14.0% | $7.22 Million | $7.22 Million | $- | $51.40 Million | ▼ -34.6 pp |
| 2002 | 48.7% | $8.26 Million | $8.26 Million | $- | $16.96 Million | ▼ -256.3 pp |
| 2001 | 305.0% | $10.29 Million | $10.29 Million | $- | $3.37 Million | — |